The Best Marijuana and Precision Medicine Stocks to Buy Might Not Be the Companies You Think

The marijuana market may be on its way to being worth $25 billion in 2021, and advances in DNA research could lead to next-generation precision medicine worth billions of dollars in annual sales. Yet, picking the winners and losers in these markets is a gamble.

Legislation could derail marijuana's momentum, and over 90% of medicines that enter clinical trials have historically ended up in laboratory dustbins, not on pharmacy shelves.

A better investment option might be to focus on Scotts Miracle-Gro (NYSE: SMG) and Illumina (NASDAQ: ILMN); two companies that supply the "picks and shovels" needed by companies that are targeting these market opportunities.

Source: Fool.com